J&J, Bayer Rip FDA's Over-The-Counter Reforms
Leading pharmaceutical companies, including Johnson & Johnson and Bayer Healthcare LLC, are challenging the U.S. Food and Drug Administration's proposal to use administrative orders instead of formal rulemaking to regulate over-the-counter...To view the full article, register now.
Already a subscriber? Click here to view full article